Bioshin

bioshin is a wholly-owned subsidiary of biohaven pharmaceuticals, a public biotech company based in new haven, ct, usa (nyse:bhvn). bioshin is a clinical-stage biopharmaceutical company focused on developing medicines for the asia-pacific region. it has proven leadership from global industry and academic settings and a portfolio of innovative, late-stage product candidates targeting neurological and neuropsychiatric diseases, including rare disorders. we’re using a flat and highly entrepreneurial organizational structure – and deep experience in drug development – to leverage a range of intellectual property licensed from companies and institutions that include bristol-myers squibb company, astrazeneca ab, yale university, catalent, als biopharma llc and massachusetts general hospital.